Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 45.60
+0.15 (0.33%)
Jun 6, 2025, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 24.78 billion as of June 6, 2025. Its market cap has increased by 206.04% in one year.
Market Cap
24.78B
Enterprise Value
27.80B
Revenue
6.09B
Ranking
n/a
PE Ratio
28.38
Stock Price
45.60
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has decreased from 26.66B to 24.78B, a decrease of -7.04%. That is a compound annual growth rate of -1.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 240.35B |
| Hansoh Pharmaceutical Group Company | 157.27B |
| JD Health International | 126.08B |
| Innovent Biologics | 119.26B |
| WuXi Biologics | 101.31B |
| CSPC Pharmaceutical Group | 89.83B |
| Sino Biopharmaceutical | 81.02B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.74B |